Delivery Order SPE2DB24D2205-SPE2DB24FDTAY
Award Date 4/22/24
Potential Completion Date 4/23/24
Potential Value $7.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,653.80 firm fixed-price delivery order has a completion date of June 20, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $8,462.99, is a firm fixed-price delivery order for 4,568,677,123 units of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract has an ultimate completion date of July 1, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price of $11,374.08 and an ultimate completion date of May 31, 2024. This contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $4,647.12 for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract, which has a completion date of June 28, 2024, was awarded by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
- The Defense Logistics Agency (DLA) awarded a delivery order contract worth $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a $5,268.40 firm fixed-price delivery order to Amerisourcebergen Drug Corporation's Corporate Office Division for the supply of 4,565,285,746 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML medical product. This delivery order was issued under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical and medical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical supplier to the U.S. government. The $4,647.12 firm fixed-price delivery order is for 4,564,437,255 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML product, with a completion date of April 30, 2024. The contract has no set-aside designation. Amerisourcebergen, a subsidiary of the larger Cencora, Inc. parent company, holds a significant...
- This federal contract award, valued at $4,906.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of 4,565,477,796 units of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with an ultimate completion date of August 19, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $9,719.73 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,564,804,524 units of the MONOVISC 88 MG/4 ML SYRINGE 4ML pharmaceutical product. This Delivery Order contract has a firm fixed price and an ultimate completion date of June 5, 2024. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the...